---
title: "Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285442035.md"
description: "Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News"
datetime: "2026-05-06T13:15:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285442035.md)
  - [en](https://longbridge.com/en/news/285442035.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285442035.md)
---

# Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News

### Related Stocks

- [PBYI.US](https://longbridge.com/en/quote/PBYI.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Puma Biotech CFO Maximo F. Nougues disposes of 9,386 shares for $77,560.24](https://longbridge.com/en/news/292125961.md)
- [Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | PBYI Stock News](https://longbridge.com/en/news/281577081.md)
- [Bollard Group LLC Reduces Position in Aclaris Therapeutics, Inc. $ACRS](https://longbridge.com/en/news/293815783.md)
- [Scorpio Gold pursues Nasdaq listing for American depositary shares](https://longbridge.com/en/news/293905134.md)
- [Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% Stake](https://longbridge.com/en/news/293795714.md)